Review
Published on 20 Jun 2022
Dissecting the Roles of PDCD4 in Breast Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.855807
- 5,041 views
- 26 citations
Type at least 3 characters
1,768 articles
Articles
Brief Research Report
Published on 17 Jun 2022
Changes in the Transcriptome and Chromatin Landscape in BRAFi-Resistant Melanoma Cells
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.937831
- 2,613 views
- 3 citations
Original Research
Published on 16 Jun 2022
Increased Methyl-CpG-Binding Domain Protein 2 Promotes Cigarette Smoke-Induced Pulmonary Hypertension
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.879793
- 2,929 views
- 4 citations
Original Research
Published on 16 Jun 2022
SEMA3C Supports Pancreatic Cancer Progression by Regulating the Autophagy Process and Tumor Immune Microenvironment
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.890154
- 5,772 views
- 19 citations
Review
Published on 09 Jun 2022
Role of Adenoviruses in Cancer Therapy
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.772659
- 8,282 views
- 8 citations
Hypothesis and Theory
Published on 08 Jun 2022
Role of β3-Adrenergic Receptor in Bone Marrow Transplant as Therapeutical Support in Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.889634
- 2,069 views
- 1 citation
Systematic Review
Published on 06 Jun 2022
ANO1: More Than Just Calcium-Activated Chloride Channel in Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.922838
- 6,079 views
- 11 citations
Review
Published on 06 Jun 2022
Targeting TMEM88 as an Attractive Therapeutic Strategy in Malignant Tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.906372
- 3,179 views
- 3 citations
Original Research
Published on 03 Jun 2022
PBRM1 Deficiency Sensitizes Renal Cancer Cells to DNMT Inhibitor 5-Fluoro-2’-Deoxycytidine
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.870229
- 3,591 views
- 3 citations
Brief Research Report
Published on 02 Jun 2022
Soluble PD-L1 Expression After Intravenous Treatment of Cancer Patients With Selenite in Phase I Clinical Trial
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.906134
- 1,858 views
- 4 citations
Review
Published on 02 Jun 2022
Present and Future Perspective on PLK1 Inhibition in Cancer Treatment
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.903016
- 13,241 views
- 62 citations
Original Research
Published on 01 Jun 2022
Differential Gene Expression and Weighted Correlation Network Dynamics in High-Throughput Datasets of Prostate Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.881246
- 6,304 views
- 18 citations
Original Research
Published on 31 May 2022
Carnosol Induces p38-Mediated ER Stress Response and Autophagy in Human Breast Cancer Cells
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.911615
- 3,623 views
- 21 citations
Review
Published on 30 May 2022
Effects of N6-Methyladenosine Modification on Cancer Progression: Molecular Mechanisms and Cancer Therapy
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.897895
- 2,403 views
Original Research
Published on 27 May 2022
Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting With miR-140 and miR-143
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.912935
- 2,533 views
- 13 citations
Original Research
Published on 26 May 2022
Anlotinib for Recurrent or Metastatic Primary Malignant Bone Tumor: A Multicenter, Single-Arm Trial
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.811687
- 2,605 views
- 11 citations